Skip to main content

Rigel Pharmaceuticals Inc 10-Q for FY2022 Q2

Rigel Pharmaceuticals Inc (RIGL)

10-Q 2022-08-02 For: 2022-06-30
View Original
Added on April 06, 2026

About this 10-Q

Rigel Pharmaceuticals Inc filed this 10-Q on August 2, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).

Headline figures

Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$29.82M
up 13.5% from $26.27M a year earlier
Net loss
$13.49M
compared with a net loss of $13.82M a year earlier
Diluted EPS
-$0.08
compared with -$0.08 a year earlier